Skip to main content
Premium Trial:

Request an Annual Quote

GSK Extends Adverse-Event Pharmacogenomics Pact with FGT

NEW YORK, May 25 (GenomeWeb News) - First Genetic Trust said today that it will use its enTrust genetic banking platform in a research collaboration with GlaxoSmithKline to study the relationship between genetic variations and certain adverse drug reactions.

 

The companies entered a similar collaboration in October 2001. FGT called the new agreement a "further research collaboration" with GSK, but did not provide details on whether the expanded effort is a renewal of the original agreement or a new project.   

 

FGT said that GSK will use enTrust to collect, store, and manage patient enrollment, informed consent, and clinical data to support the project.

 

The system will also be used to re-contact patients online for additional consent for new research or phenotypic information, FGT said.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.